- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Resectable Hepatocellular Carcinoma in Colombia
Total 1176 results
-
University of British ColumbiaCompletedUnresectable Hepatocellular Carcinoma | Undergoing Chemoembolization and RadioembolizationCanada
-
Jonsson Comprehensive Cancer CenterBayerCompletedLocalized Resectable Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular CarcinomaUnited States
-
BayerRecruitingUnresectable Hepatocellular CarcinomaGreece, Brazil, China, Colombia, Italy, Korea, Republic of, Saudi Arabia, Spain, Taiwan, Thailand, United States, Argentina, France, Mexico, Turkey
-
National Cancer Institute (NCI)CompletedAdvanced Adult Hepatocellular Carcinoma | Localized Non-Resectable Adult Liver Carcinoma | Recurrent Adult Liver Carcinoma | Recurrent Gallbladder Carcinoma | Stage IV Distal Bile Duct Cancer | Stage IV Gallbladder Cancer | Unresectable Extrahepatic Bile Duct Carcinoma | Unresectable Gallbladder...United States
-
National Cancer Institute (NCI)CompletedHepatocellular Carcinoma | Unresectable Hepatocellular CarcinomaUnited States
-
Boston Scientific CorporationBiocompatibles UK LtdCompletedUnresectable Hepatocellular CarcinomaKorea, Republic of, United States, Spain, France, United Kingdom, Canada, Germany, Singapore, Netherlands, Belgium, Italy
-
National Cancer Institute (NCI)CompletedUnresectable Hepatocellular Carcinoma | Advanced Adult Hepatocellular Carcinoma | Recurrent Hepatocellular Carcinoma | Stage IIIB Hepatocellular Carcinoma AJCC v7 | Stage IIIC Hepatocellular Carcinoma AJCC v7 | Stage IV Hepatocellular Carcinoma AJCC v7 | Stage III Hepatocellular Carcinoma AJCC v7 and other conditionsUnited States, Canada, Puerto Rico
-
British Columbia Cancer AgencyUnknown
-
University of British ColumbiaCompleted
-
Alexander KimSurefire Medical, Inc.Unknown
-
Georgetown UniversityAbbottTerminated
-
National Cancer Institute (NCI)Recruiting
-
TularikUnknownHepatocellular CarcinomaUnited States, China
-
British Columbia Cancer AgencyBC Cancer Foundation; Pancreatic Cancer CanadaUnknownResectable Pancreatic Ductal AdenocarcinomaCanada
-
University Health Network, TorontoNational Cancer Institute (NCI)Completed
-
Johns Hopkins UniversityM.D. Anderson Cancer CenterWithdrawnHepatocellular Carcinoma | CirrhosisUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedLocalized Non-Resectable Adult Liver CarcinomaUnited States
-
British Columbia Cancer AgencyWithdrawnLiver Cirrhosis | Hepatocellular Carcinoma | Chronic Liver DiseaseCanada
-
Aiwu Ruth He, MDGeorgetown University; Genentech, Inc.TerminatedHepatocellular CarcinomaUnited States
-
Surefire Medical, Inc.Terminated
-
Daiichi Sankyo, Inc.CompletedLiver Neoplasms | Advanced Hepatocellular Carcinoma | Liver Cancer | Hepatic CancerKorea, Republic of, Taiwan, United States, Japan
-
Surefire Medical, Inc.Terminated
-
National Cancer Institute (NCI)RecruitingPancreatic Acinar Cell Carcinoma | Pancreatic Adenosquamous Carcinoma | Pancreatic Squamous Cell Carcinoma | Resectable Pancreatic Acinar Cell Carcinoma | Resectable Pancreatic Adenocarcinoma | Resectable Pancreatic Adenosquamous Carcinoma | Resectable Pancreatic CarcinomaUnited States
-
H3 Biomedicine Inc.Eisai Inc.CompletedLiver Neoplasms | Hepatocellular Carcinoma | Advanced Hepatocellular Carcinoma | Liver Cancer | Hepatic Cancer | Hepatic CarcinomaFrance, United States, Belgium, Spain, Taiwan, Korea, Republic of, Russian Federation, Canada, Italy, Singapore, United Kingdom
-
British Columbia Cancer AgencyUniversity of British ColumbiaUnknown
-
Tvardi Therapeutics, IncorporatedRecruitingHepatocellular CarcinomaUnited States
-
Astex Pharmaceuticals, Inc.CompletedHepatocellular CarcinomaUnited States, United Kingdom, Canada
-
Merit Medical Systems, Inc.TerminatedHepatocellular CarcinomaUnited States, France, Belgium, Greece, Italy
-
Eisai LimitedMerck Sharp & Dohme LLCCompletedHepatocellular Carcinoma (HCC)Italy, Korea, Republic of, Poland, United States, Australia, Belgium, Canada, China, France, Germany, Hong Kong, Israel, Japan, Malaysia, Philippines, Russian Federation, Singapore, Spain, Taiwan, Thailand, United Kingdom
-
Boston Scientific CorporationBiocompatibles UK LtdRecruitingHepatocellular CarcinomaUnited States, Spain, France
-
AstraZenecaRecruitingA Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma (ATHENA)Hepatocellular CarcinomaUnited States, Korea, Republic of
-
University of Missouri-ColumbiaRecruitingGastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Non-small Cell Lung Cancer | Hepatocellular CancerUnited States
-
Georgetown UniversityAstraZenecaRecruitingBiliary Tract Cancer | Borderline Resectable CarcinomaUnited States
-
Daiichi Sankyo, Inc.ArQule, Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary...CompletedHepatocellular CarcinomaUnited States, France, Italy, Germany, Spain, Switzerland, Belgium, Portugal, Netherlands, Australia, Brazil, Canada, Austria, New Zealand, Sweden, Argentina
-
University Health Network, TorontoPancreatic Cancer CanadaActive, not recruitingResectable Pancreatic CancerCanada
-
Eli Lilly and CompanyCompletedHepatocellular CarcinomaItaly, United States, Spain, China, Korea, Republic of, Taiwan, France, Japan, Germany, Belgium, Austria, Brazil, Czechia, Canada, Poland, United Kingdom, Israel, Australia, Hong Kong, Switzerland
-
Bristol-Myers SquibbCompletedHepatocellular CarcinomaUnited States, Argentina, Australia, Canada, China, France, Hong Kong, Italy, Japan, Korea, Republic of, Taiwan, Thailand, Spain
-
University of Missouri-ColumbiaHarry S. Truman Memorial Veterans' HospitalRecruitingGastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Non Small Cell Lung Cancer | Hepatocellular CancerUnited States
-
ExelixisActive, not recruitingHepatocellular CarcinomaUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Colombia, Czechia, France, Georgia, Germany, Hong Kong, Hungary, Ireland, Israel, Italy, Korea, Republic of, Mexico, Netherlands, New Zealand, Philippines, ... and more
-
AstraZenecaActive, not recruitingHepatocellular CarcinomaUnited States, Canada, Brazil, France, Italy, Russian Federation, Spain, Vietnam, Korea, Republic of, China, Germany, Ukraine, Japan, Hong Kong, Taiwan, India, Thailand
-
National Cancer Institute (NCI)Active, not recruitingHepatocellular Carcinoma | CirrhosisUnited States, Puerto Rico
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingHepatocellular CarcinomaUnited States, Singapore, Spain, United Kingdom, Germany, Italy, Canada, France, Hong Kong, Japan, Korea, Republic of, Puerto Rico, Taiwan
-
ImunonCompletedHepatocellular CarcinomaUnited States, Taiwan, Korea, Republic of, China, Italy, Hong Kong, Thailand, Canada, Malaysia, Japan, Philippines
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedHepatocellular CarcinomaUnited States, Australia, Austria, Belgium, Canada, China, Czechia, France, Germany, Hong Kong, Israel, Italy, Japan, Korea, Republic of, Poland, Russian Federation, Singapore, Spain, Sweden, Switzerland, Taiwan, United Kingdom
-
Bristol-Myers SquibbActive, not recruitingHepatocellular CarcinomaGermany, Romania, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Czechia, France, Hong Kong, Italy, Japan, Korea, Republic of, Poland, Puerto Rico, Russian Federation, Singapore, Spain, Switzerland and more
-
AstraZenecaActive, not recruitingHepatocellular CarcinomaUnited States, Canada, France, Taiwan, Thailand, Vietnam, Italy, Korea, Republic of, Brazil, India, Japan, Mexico, Russian Federation, China, Hong Kong, Australia, Spain, Singapore
-
Target PharmaSolutions, Inc.RecruitingHepatocellular CancerUnited States, Germany, France, Italy, Spain
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)Active, not recruitingMetastatic Small Intestinal Adenocarcinoma | Recurrent Small Intestinal Carcinoma | Unresectable Small Intestinal CarcinomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Head and Neck Squamous Cell Carcinoma | Metastatic Head and Neck Squamous Cell Carcinoma | Unresectable Head and Neck Squamous Cell CarcinomaUnited States
-
Jennerex BiotherapeuticsCompletedHCC | Hepatocellular Carcinoma | Liver CancerKorea, Republic of, United States, Hong Kong, Canada, Germany, France, Taiwan